CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[FORM OF RESTRICTED SHARE AWARD AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC. * * * * * Participant: _______ Number of Restricted Shares granted: _______ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Restricted Share Award . Vesting 3.1 · _______________________________________ 3.2 3.3 If the Participant’s employment with the] [FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC * * * * * Optionee: ________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Option . 3. No Dividends Equivalents . 4.] [EMPLOYMENT AGREEMENT 聘用协议 May 31 Agreement Company nd Employee ### ## #### Parties This EMPLOYMENT AGREEMENT is made and entered into on — 17 2 570216 ### ## #### 2011-5- 31. 这份协议是由中国医药控股有限公司(“公司”) WITNESSETH: 条款 WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and 鉴于,公司是一家在中国从事研发,生产,销售的专业的制药企业。并且 WHEREAS, Employee has represented]

By | 2016-03-03T19:28:25+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By | 2016-02-07T22:57:57+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By | 2016-02-07T22:58:51+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] SC 13D: SAIF Partners IV L.P. Andrew Y. Yan Director

[SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is SAIF IV GP L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P. SAIF IV GP Capital Ltd. Andrew Y. Yan Director of SAIF IV GP Capital Ltd.] [CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]

By | 2016-03-24T01:58:55+00:00 May 31st, 2011|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:45:16+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts

[Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These plans allow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-03-03T12:46:25+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-02-07T16:11:59+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share

[Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public]

By | 2016-02-07T16:12:50+00:00 May 25th, 2011|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:01+00:00 May 24th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]

By | 2016-03-01T05:18:40+00:00 May 24th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar